SENSOMATT

At SENSOMATT, we are passionate about creating a healthier, more comfortable world for those at risk of developing pressure ulcers. Our innovative cushion is equipped with patented sensors and AI Core

SENSOMATT has made significant progress in traction and current status. We have conducted successful tests in collaboration with Salvador Association in Portugal, focusing on disabilities and related issues. Our working prototype hardware is complete, and we are currently in the process of developing the accompanying mobile app. These milestones demonstrate our commitment to delivering a finalized innovative solution to prevent pressure ulcers among wheelchair users in next 3-4 months.

SENSOMATT is solving the critical problem of pressure ulcers among wheelchair users. These ulcers result from prolonged immobility, leading to painful wounds that are challenging to treat. The risk of pressure ulcers significantly impacts the quality of life for wheelchair users, causing pain and discomfort. Our startup aims to address this issue by providing innovative solutions that detect and prevent pressure ulcers, improving the well-being and comfort of wheelchair users worldwide.

Wheelchair users can prevent pressure ulcers with SENSOMATT. The user's micro-movements are monitored by our smart cushion's patented sensors. The data is sent to our cloud-based server, which analyzes it via a pre trained AI algorithm. A mobile app provides real-time pressure ulcer prevention advice and suggestoins. Our technology promotes regular movement and relieves pressure points to improve wheelchair users' health and quality of life by reducing the risk of painful pressure ulcers.

SENSOMATT's business model revolves around selling smart cushions to wheelchair users, healthcare facilities, and individuals at a competitive price. Revenue is generated through direct sales and partnerships with wheelchair manufacturers. Additionally, subscription plans for premium features and data analytics are offered to users. Continuous innovation and R&D investments ensure a sustainable growth trajectory while meeting the demand for pressure ulcer prevention solutions worldwide.

EIT Digital Venture Program 2019
MoveUp Program 2020
EIT Health Patient Innovation Program 2022